Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 13/20 | 0.47 |
| ▸ | RORC | P51449 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7984122 | 0.91 | HSD11B1 (0.47) | HSD11B1LMNANPC1ALDH1A1RAB9A | |
| SCHEMBL7987984 | 0.88 | HSD11B1 (0.50) | HSD11B1 | |
| SCHEMBL7967520 | 0.85 | HSD11B1 (0.42) | HSD11B1RORCLMNAMAPTTSHR | |
| SCHEMBL12671009 | 0.84 | HSD11B1 (0.44) | HSD11B1RORC | |
| SCHEMBL7977555 | 0.82 | HSD11B1 (0.49) | HSD11B1LMNANPC1ALDH1A1RAB9A | |
| SCHEMBL7988091 | 0.78 | HSD11B1 (0.43) | HSD11B1RORCLMNAMAPTTSHR | |
| SCHEMBL12671016 | 0.78 | HSD11B1 (0.45) | HSD11B1 | |
| SCHEMBL7977558 | 0.77 | HSD11B1 (0.49) | HSD11B1LMNANPC1ALDH1A1RAB9A | |
| SCHEMBL7985076 | 0.76 | HSD11B1 (0.51) | HSD11B1RAB9ASMN1; SMN2 | |
| SCHEMBL7982228 | 0.76 | HSD11B1 (0.51) | HSD11B1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010001946-A1 | TRIAZOLE DERIVATIVE OR SALT THEREOF | アステラス製薬株式会社 (JP) | 2010-01-07 | — | — | WO | disclosed |